INR 1059.65
(-1.01%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 3.62 Billion INR | 33.62% |
2022 | 1.22 Billion INR | -19.72% |
2021 | 1.52 Billion INR | 30.03% |
2020 | 1.17 Billion INR | 38.39% |
2019 | 849.13 Million INR | 22.35% |
2018 | 694.04 Million INR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 446.03 Million INR | -4.72% |
2023 Q1 | 356.48 Million INR | -5.57% |
2023 Q2 | 436.77 Million INR | 22.52% |
2023 Q3 | 377.64 Million INR | -13.54% |
2023 FY | 1.63 Billion INR | 33.62% |
2023 Q4 | 468.12 Million INR | 23.96% |
2022 Q1 | 257.17 Million INR | -21.05% |
2022 FY | 1.22 Billion INR | -19.72% |
2022 Q4 | 377.5 Million INR | 57.29% |
2022 Q3 | 240 Million INR | -26.91% |
2022 Q2 | 328.38 Million INR | 27.69% |
2021 Q2 | 386.7 Million INR | -13.94% |
2021 FY | 1.52 Billion INR | 30.03% |
2021 Q4 | 325.75 Million INR | -6.45% |
2021 Q3 | 348.22 Million INR | -9.95% |
2021 Q1 | 449.34 Million INR | 1.34% |
2020 Q1 | 41.02 Million INR | 0.0% |
2020 Q2 | 398.94 Million INR | 872.57% |
2020 Q3 | 369.12 Million INR | -7.47% |
2020 FY | 1.17 Billion INR | 38.39% |
2020 Q4 | 443.39 Million INR | 20.12% |
2019 FY | 849.13 Million INR | 22.35% |
2018 FY | 694.04 Million INR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Krsnaa Diagnostics Limited | 696.99 Million INR | -420.6% |
Dr. Lal PathLabs Limited | 4.76 Billion INR | 23.814% |
Metropolis Healthcare Limited | 2.05 Billion INR | -76.539% |
Thyrocare Technologies Limited | 917 Million INR | -295.696% |
Vimta Labs Limited | 536.04 Million INR | -576.902% |